Diagnosis and management of heart failure.
作者信息
Dargie H J, McMurray J J
机构信息
Department of Cardiology, Western Infirmary, Glasgow.
出版信息
BMJ. 1994 Jan 29;308(6924):321-8. doi: 10.1136/bmj.308.6924.321.
Abstract
摘要
相似文献
1
Diagnosis and management of heart failure.心力衰竭的诊断与管理
BMJ. 1994 Jan 29;308(6924):321-8. doi: 10.1136/bmj.308.6924.321.
2
[Guidelines for diagnosis and treatment of heart failure].
Arch Mal Coeur Vaiss. 2002 Feb;95 Spec 2(5 Spec 2):5-53.
3
Drugs for chronic heart failure.用于慢性心力衰竭的药物。
Med Lett Drugs Ther. 1993 May 14;35(896):40-2.
4
Therapy of heart failure.
Kidney Int. 2000 Apr;57(4):1418-25. doi: 10.1046/j.1523-1755.2000.00986.x.
5
Guidelines for choosing drugs in chronic heart failure.慢性心力衰竭的药物选择指南。
Vasc Health Risk Manag. 2005;1(3):171-2.
6
ABC of heart failure. Management: diuretics, ACE inhibitors, and nitrates.心力衰竭基础知识。治疗：利尿剂、血管紧张素转换酶抑制剂及硝酸盐类药物。
BMJ. 2000 Feb 12;320(7232):428-31. doi: 10.1136/bmj.320.7232.428.
7
Heart failure: early treatment is key.
Johns Hopkins Med Lett Health After 50. 2006 Jan;17(11):4-5.
8
15 years of heart-failure trials: what have we learned?
Lancet. 1998 Aug;352 Suppl 1:SI29-33. doi: 10.1016/s0140-6736(98)90016-2.
9
[Hypertension in patients with heart failure].[心力衰竭患者的高血压]
Nihon Rinsho. 2004 Mar;62 Suppl 3:478-83.
10
[Chronic heart failure in children: recent contributions of physiopathology and therapeutic implications].
Arch Pediatr. 2001 Oct;8(10):1099-107. doi: 10.1016/s0929-693x(01)00594-2.
引用本文的文献
1
Monocyte to high-density lipoprotein ratio is associated with mortality in patients with coronary artery diseases.单核细胞/高密度脂蛋白比值与冠心病患者的死亡率相关。
BMC Cardiovasc Disord. 2023 Sep 11;23(1):451. doi: 10.1186/s12872-023-03461-y.
2
A Study of Vitamin D and Its Correlation With Severity and Complication of Congestive Heart Failure: A Systematic Review.维生素D及其与充血性心力衰竭严重程度和并发症的相关性研究：一项系统综述
Cureus. 2022 Sep 6;14(9):e28873. doi: 10.7759/cureus.28873. eCollection 2022 Sep.
3
Improving Accuracy of Heart Failure Detection Using Data Refinement.使用数据优化提高心力衰竭检测的准确性。
Entropy (Basel). 2020 May 2;22(5):520. doi: 10.3390/e22050520.
4
Qualitative Evaluation of Cardiovascular Diseases Management in Family Medicine Team in One Year Level.家庭医学团队一年水平心血管疾病管理的定性评估
Med Arch. 2015 Jun;69(3):140-4. doi: 10.5455/medarh.2015.69.140-144. Epub 2015 Jun 10.
5
Hawthorn extract for treating chronic heart failure.用于治疗慢性心力衰竭的山楂提取物
Cochrane Database Syst Rev. 2008 Jan 23;2008(1):CD005312. doi: 10.1002/14651858.CD005312.pub2.
6
7
Management of chronic heart failure: perceived needs of general practitioners in light of the new general medical services contract.慢性心力衰竭的管理：鉴于新的全科医疗服务合同，全科医生的感知需求
Postgrad Med J. 2005 May;81(955):321-6. doi: 10.1136/pgmj.2004.022947.
8
Reliability of N-terminal proBNP assay in diagnosis of left ventricular systolic dysfunction within representative and high risk populations.N末端脑钠肽前体检测在代表性及高危人群左心室收缩功能障碍诊断中的可靠性。
Heart. 2004 Aug;90(8):866-70. doi: 10.1136/hrt.2003.014258.
9
Barriers to accurate diagnosis and effective management of heart failure in primary care: qualitative study.基层医疗中准确诊断和有效管理心力衰竭的障碍：定性研究
BMJ. 2003 Jan 25;326(7382):196. doi: 10.1136/bmj.326.7382.196.
10
Impact of revascularization and myocardial viability determined by nitrate-enhanced Tc-99m sestamibi and Tl-201 imaging on mortality and functional outcome in ischemic cardiomyopathy.通过硝酸盐增强的锝-99m 甲氧基异丁基异腈和铊-201 显像测定的血运重建和心肌存活性对缺血性心肌病患者死亡率和功能转归的影响
J Nucl Cardiol. 2002 Sep-Oct;9(5):454-62. doi: 10.1067/mnc.2002.123913.
本文引用的文献
1
Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group.维司力农对心力衰竭患者发病率和死亡率的影响。维司力农研究小组。
N Engl J Med. 1993 Jul 15;329(3):149-55. doi: 10.1056/NEJM199307153290301.
2
Digoxin in heart failure.
N Engl J Med. 1993 Jul 1;329(1):51-3. doi: 10.1056/NEJM199307013290111.
3
4
The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors.比弗迪姆健康结果研究：健康状态质量因素的初始目录
Med Decis Making. 1993 Apr-Jun;13(2):89-102. doi: 10.1177/0272989X9301300202.
5
Clinical and neurohumoral response of patients with severe congestive heart failure treated with two different captopril dosages.
Eur Heart J. 1993 Feb;14(2):273-8. doi: 10.1093/eurheartj/14.2.273.
6
Diagnosis of symptomless left ventricular dysfunction.
Lancet. 1993 May 1;341(8853):1124-5. doi: 10.1016/0140-6736(93)93132-k.
7
Flosequinan.
Lancet. 1993 Mar 20;341(8847):733-6. doi: 10.1016/0140-6736(93)90498-6.
8
Captopril in heart failure. A double blind controlled trial.卡托普利治疗心力衰竭。一项双盲对照试验。
Br Heart J. 1984 Nov;52(5):530-5. doi: 10.1136/hrt.52.5.530.
9
The natural history of congestive heart failure: the Framingham study.充血性心力衰竭的自然病史：弗明汉姆研究
N Engl J Med. 1971 Dec 23;285(26):1441-6. doi: 10.1056/NEJM197112232852601.
10
Effect of propranolol after acute myocardial infarction in patients with congestive heart failure.
Circulation. 1986 Mar;73(3):503-10. doi: 10.1161/01.cir.73.3.503.
Zotero 插件